Integrated Biopharma (INBP) Akcie Kurz

Integrated Biopharma Inc is primarily active in the healthcare and pharmaceutical industries.

The main competitors of Integrated Biopharma Inc in the market include prominent companies such as Pfizer, Johnson & Johnson, Amgen, Roche Holding AG, and Novartis AG. These competitors are major players in the biopharmaceutical industry and compete with Integrated Biopharma Inc in areas including drug research and development, manufacturing, marketing, distribution, and sales.

Integrated Biopharma Inc is a reputable company with a rich history and background. Established in [year], Integrated Biopharma Inc has emerged as a leading player in the [industry] sector. The company specializes in [specific products or services] and has consistently delivered exceptional results. With a commitment to innovation and high-quality standards, Integrated Biopharma Inc has successfully developed and commercialized numerous breakthrough products. Over the years, the company has built strong partnerships, expanded its global presence, and garnered a solid reputation for reliability and customer satisfaction. Integrated Biopharma Inc continues to strive for excellence, driving growth and success in the market.

Integrated Biopharma Inc, a leading biotechnology company, has achieved several significant milestones. The company has successfully developed and commercialized a range of innovative pharmaceutical and dietary supplement products. Integrated Biopharma Inc has made notable strides in research and development, driving advancements in various therapeutic areas. With a focus on ensuring quality and safety, the company has obtained regulatory approvals for its products, further enhancing its market presence. Additionally, their commitment to continuous innovation and strategic partnerships has supported the company's growth and expanded its global reach. Integrated Biopharma Inc continues to make strides in the healthcare industry, establishing itself as a trusted and successful player.

Integrated Biopharma Inc is primarily present in countries and regions across the globe. With its global reach, the company has a strong presence in the United States, Europe, Asia, and other international markets. This diversified geographical presence allows Integrated Biopharma Inc to leverage various opportunities and cater to a wide customer base. By operating in multiple countries and regions, the company is able to tap into different market dynamics, expand its distribution network, and effectively serve its customers worldwide. Integrated Biopharma Inc's international presence is testament to its commitment to global growth and the delivery of its high-quality products and services.

Integrated Biopharma Inc represents values of innovation, scientific excellence, and commitment to improving human health. With a focus on the development, manufacturing, and marketing of high-quality nutraceutical and pharmaceutical products, the company prioritizes research-driven approaches to deliver effective solutions. Integrated Biopharma Inc embraces a corporate philosophy centered on enhancing wellness and longevity through its diverse portfolio of products. By constantly pushing the boundaries of biotechnology and prioritizing customer satisfaction, the company has established itself as a trusted name in the industry. Integrated Biopharma Inc's dedication to cutting-edge science and ethical business practices makes it a leader in the field of biopharmaceuticals.

Při aktuálním kurzu se akcie Integrated Biopharma obchoduje za 0,15 EUR (0,17 USD).

Integrated Biopharma Inc. is a diversified company specializing in the discovery, development, and marketing of innovative products in the fields of health, nutrition, and wellness. The company was founded in 1979 and is headquartered in New York, USA. The business model of Integrated Biopharma Inc. is based on various divisions, including the sale of raw materials, research and development, manufacturing of dietary supplements, and licensing of patents and technologies. The company offers a wide range of products, including natural raw materials such as herbs, extracts, and powders used in the manufacturing of dietary supplements and pharmaceutical products. Some of its well-known products include probiotics that improve gut health and digestion, as well as vitamins and minerals that help support a healthy lifestyle. Another division of Integrated Biopharma Inc. is research and development of new products. The company has its own research laboratory where innovative technologies and processes are developed to enhance the efficacy and safety of dietary supplements and drugs. The manufacturing of dietary supplements and pharmaceutical products is another important division of Integrated Biopharma Inc. The company operates its own production facilities and has extensive experience in producing products in compliance with the high-quality standards of the Food and Drug Administration (FDA). In addition to these divisions, Integrated Biopharma Inc. also offers licensing of patents and technologies. The company holds a variety of patents on innovative technologies in the fields of health, nutrition, and wellness and offers them for licensing. The business model of Integrated Biopharma Inc. is based on long-term relationships with customers and partners built on trust and quality. The company emphasizes collaboration with customers in product development and provides comprehensive customer service to ensure customer satisfaction. In summary, the business model of Integrated Biopharma Inc. is focused on the discovery, development, and marketing of innovative products in the fields of health, nutrition, and wellness. The company has divisions including raw materials, research and development, manufacturing of dietary supplements, and licensing of patents and technologies. Integrated Biopharma Inc. values quality and customer relationships and offers comprehensive customer service as well as long-term partnerships with customers and partners.

Tržby za Integrated Biopharma činí 43,87 Mil. USD. Tato hodnota je založena na aktuálních finančních údajích a odráží výkonnost společnosti.

Zisk za Integrated Biopharma činí -2,84 Mil. USD. Čistý zisk odráží ziskovost společnosti po odečtení všech nákladů.

Poměr ceny k zisku (P/E) Integrated Biopharma je aktuálně -1,86. Poměr P/E porovnává aktuální cenu akcie se ziskem na akcii a pomáhá investorům posoudit ocenění akcie Integrated Biopharma.

Poměr ceny k tržbám (P/S) Integrated Biopharma je aktuálně 0,12. Poměr P/S porovnává tržní kapitalizaci s ročními tržbami a slouží jako metrika ocenění akcie Integrated Biopharma.

Score kvality pro Integrated Biopharma je 1/10.

ISIN Integrated Biopharma je US45811V1052. ISIN (International Securities Identification Number) je celosvětově jedinečný identifikátor cenných papírů.

WKN Integrated Biopharma je 120093. WKN (Wertpapierkennnummer) je šestimístný německý identifikační kód cenného papíru.

Ticker Integrated Biopharma je INBP. Symbol tickeru se používá k obchodování akcií Integrated Biopharma na burze.